0001415889-19-000233.txt : 20190301 0001415889-19-000233.hdr.sgml : 20190301 20190228182224 ACCESSION NUMBER: 0001415889-19-000233 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190301 DATE AS OF CHANGE: 20190228 EFFECTIVENESS DATE: 20190301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-333838 FILM NUMBER: 19645652 BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 D 1 primary_doc.xml X0708 D LIVE 0001604191 AzurRx BioPharma, Inc. 760 Parkside Ave. Suite 304 Brooklyn NY NEW YORK 11226 646-699-7855 DELAWARE None BioPharma d'Azur, Inc. Corporation true Johan Spoor 760 Parkside Ave. Suite 304 Brooklyn NY NEW YORK 11226 Executive Officer Director Edward Borkowski 760 Parkside Ave. Suite 304 Brooklyn NY NEW YORK 11226 Director Alastair Riddell 760 Parkside Ave. Suite 304 Brooklyn NY NEW YORK 11226 Director Maged Shenouda 760 Parkside Ave. Suite 304 Brooklyn NY NEW YORK 11226 Executive Officer Director Charles Casamento 760 Parkside Ave. Suite 304 Brooklyn NY NEW YORK 11226 Director Vern Schramm 760 Parkside Ave. Suite 304 Brooklyn NY NEW YORK 11226 Director Daniel Dupret 760 Parkside Ave. Suite 304 Brooklyn NY NEW YORK 11226 Executive Officer James Pennington 760 Parkside Ave. Suite 304 Brooklyn NY NEW YORK 11226 Executive Officer Biotechnology No Revenues 06b false 2019-02-14 false true true false 1000000 2000000 2000000 0 false 0 1 0 0 0 AzurRx BioPharma, Inc. /s/ Johan M. Spoor Johan M. Spoor President and CEO 2019-02-28